Virtual Kol Event: RZ402 - An Oral Plasma Kallikrein Inhibitor for DME - Wednesday, March 22, 2023 at 4:30 PM Edt

Learn More »

Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability

Back to Careers

Stay Connected

Sign up for alerts to stay up to date with our latest news and learn
what our team has been up to on Facebook, LinkedIn, and Twitter.

Email Alerts RSS News Feed
MENU